NanoViricides Inc. (NNVC)

[leifsmith]

The big payoff from government that Patrick Cox described would not cost the government anything. It would be in the form of a fast-track voucher to speed the way through the FDA approval process. And, it would be available to the company only AFTER their first drug had already been approved. This voucher could then be used for the second drug, or it could be sold to another company. Some estimates of the value of such a voucher were as high as $300 million. So far in the future that small current progress cannot be expected to have much voucher-related effect on current stock price beyond whatever may already be priced into it.

daBose - this isn't actually a response to something I recall you asking, but someone did and the question kind of began this thread.